 Coronary artery disease CAD is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular CV disease at risk for major adverse cardiac events MACE, the identification of these patients remains a clinical challenge. 